Price v. Centurion of Delaware, LLC

CourtDistrict Court, D. Delaware
DecidedJune 13, 2025
Docket1:23-cv-01062
StatusUnknown

This text of Price v. Centurion of Delaware, LLC (Price v. Centurion of Delaware, LLC) is published on Counsel Stack Legal Research, covering District Court, D. Delaware primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Price v. Centurion of Delaware, LLC, (D. Del. 2025).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE MILLARD E. PRICE, ) ) Plaintiff, ) ) V. ) Civ. No. 23-1062-CFC ) CENTURION OF DELAWARE, ) LLC, et al., ) ) Defendants. )

Millard E. Price, Howard R. Young Correctional Institution, Wilmington, Delaware — Pro se Plaintiff Dawn C. Doherty, Brett Thomas Norton, and Georgia Catherine Pham, MARKS, O’ NEILL, O’ BRIEN, DOHERTY & KELLY, P.C., Wilmington, Delaware — Counsel for Defendants Centurion of Delaware, LLC, Christine Onafrio, Jacklyn S. Martin, and Maryann A. Muhammad

MEMORANDUM OPINION

June 13, 2025 Wilmington, Delaware

CLF: CONNOLLY, Chief Judge: On September 27, 2023, Plaintiff Millard E. Price, an inmate at the Howard R. Young Correctional Institution (HRYCI) in Wilmington, Delaware, initiated this civil action pro se with the filing of the Complaint and a motion for leave to proceed in forma pauperis. (D1. 1, 2.) Now pending before the Court is a motion to dismiss the Complaint filed on behalf of Defendants Centurion of Delaware, LLC, Christine Onafrio, Jacklyn S$. Martin, and Maryann A. Muhammad (the moving Defendants). (D.I.28.) The Court grants the motion to dismiss in part, and denies the motion to dismiss in part, for the reasons explained below. I. BACKGROUND According to the Complaint, Plaintiff lives with chronic pain and neuropathy resulting from a serious spinal condition, for which he underwent two corrective or palliative surgeries in 2019 and 2020. (D.I.2at1,8.) Plaintiffs chronic pain was treated effectively with Tramadol from 2017 to 2020, in accordance with the recommendation of one of Plaintiff's surgeons. (/d.) Thereafter, medical staff for Defendant Centurion (HRYCI’s medical services provider at the time) informed Plaintiff that they could no longer prescribe Tramadol for Plaintiff's chronic pain due to an unspecified medical policy. (/d.) Centurion providers required Plaintiff to stop taking Tramadol “cold turkey,” and they prescribed him Tylenol in lieu of Tramadol for pain. (/d. at 2, 8.)

In 2021, an outside specialist evaluated Plaintiff, recommended Tramadol for pain management, and recommended further evaluation by a neurosurgeon. (/d.) On this recommendation, a Centurion nurse practitioner, Defendant Muhammad, prescribed Plaintiff Tramadol in early November 2021 and referred Plaintiff to

neurosurgery. (id. at 10.) Approximately four months and three weeks later, Defendant Crosby, a clinical pharmacist for Centurion, met with Plaintiff and informed him that a medical policy prohibited the use of Tramadol for chronic non-cancer-related pain management. (/d.) Defendant Crosby told Plaintiff that he would recommend Cymbalta in lieu of Tramadol for Plaintiff's chronic pain, even though Plaintiff told Defendant Crosby that he could not take Cymbalta due to the potential side effects. (/d.) Several days later, Defendant Muhammad confirmed that Plaintiff's Tramadol prescription was being terminated due to the medical policy prohibiting the use of Tramadol for chronic pain unrelated to cancer. (Jd. at 11.) Defendant Muhammad prescribed Cymbalta over Plaintiff's objection and explained that she

was not required to adhere to the outside specialist’s 2021 recommendations. (/d.) Defendant Muhammad made this decision with knowledge of Plaintiff’s condition as his provider. (/d.) Defendant Muhammad had reviewed Plaintiffs 2021 MRI results, which revealed herniated discs and other spinal problems, and she had

reviewed the assessment of a secondary outside specialist, who stated that Plaintiff

may suffer “total denervation and use of [his] left leg” if his spinal issues were not addressed. (id. at 9.) Plaintiff submitted a medical grievance regarding the change in medication from Tramadol to Cymbalta, which was denied, and Plaintiff appealed, but the determination was upheld. (/d.at12.) Over a month after the change in medication, Plaintiff submitted a sick call request for ongoing pain, and Defendant Muhammad responded, telling Plaintiff that Centurion’s medical director, Defendant Martin, had cancelled Plaintiff's treatment with the outside specialist who evaluated Plaintiff in 2021. (qd.) Despite cancellation of treatment with the outside specialist, approximately eight months and one week after the outside specialist recommended further evaluation by a neurosurgeon, a neurosurgeon evaluated Plaintiff. (Ud. at 13.) The neurosurgeon assessed Plaintiff's condition as severe and recommended a third spinal surgery but could not say whether surgery would alleviate Plaintiff’s chronic pain, so Plaintiff requested a second opinion. (ld. at3,13.) Plaintiff submitted repeated sick calls and a medical grievance following the visit with the

neurosurgeon, but Centurion providers did not give Plaintiff with the opportunity to seek a second opinion. (/d.)

Approximately seven months and three weeks after the neurosurgeon’s evaluation, Defendants Martin and Muhammad met with Plaintiff regarding his situation. (/d. at 14.) During the meeting, Defendant Martin told Plaintiff, “We know you are in pain[,] so please stop with the sick calls[. ]Work with us and we’ll

try to help you,” and Defendant Muhammad told Plaintiff, “I had to terminate your Tramadol. I was under the impression you would be getting surgery in a couple of months.” (/d.) Approximately one month and one week after the meeting with Defendants Martin and Muhammad, Defendants Martin and Crosby met with Plaintiff to discuss possible alternatives to Tramadol, all of which Plaintiff rejected. (Ud.) Plaintiff rejected these alternative drugs because, like Cymbalta, they were antidepressants, and Plaintiff was concerned about their efficacy and side effects. (Jd. at 14, 17.) During this meeting, Plaintiff stated that if he was not going to receive authorization to seek a second opinion, he wanted to move forward with the third spinal surgery. at 14.) One week later, Defendants Martin and Onafrio met with Plaintiff to reschedule Plaintiff's spinal surgery with the neurosurgeon. (/d.) A week after that meeting, Defendant Martin prescribed Pamelor in lieu of Tramadol for Plaintiffs chronic pain. (/d.) Like Cymbalta, Pamelor was an antidepressant, so Plaintiff did not think it was appropriate for pain management in his case. (J/d.)

After being prescribed Pamelor for two weeks, Plaintiff sent Defendant Martin a letter, informing him that Pamelor was having no effect on his pain. (dd. at 14-15.) Plaintiff sent Defendant Martin a second letter, stating the same, one week later. (Id. at 15.) Approximately ten months and one week after the neurosurgeon’s evaluation, and one month and two weeks after Plaintiff had agreed to the third spinal surgery, Defendant Martin informed Plaintiff that the neurosurgeon had been replaced with

a new neurosurgeon, who would require Plaintiff to undergo anew MRI and physical therapy before reevaluating him for surgery. (/d. at 3, 15.) Defendant Martin increased Plaintiff's dosage of Pamelor and said Plaintiff would see the new

neurosurgeon in two or three months. (/d. at 15.) As the three-month mark approached, and then passed, Plaintiff wrote letters to Defendants Onafrio and Martin to inquire about his appointment with the new

neurosurgeon and to relay that Pamelor was having no effect on his pain. □□□□□ Plaintiff then learned that he could not be scheduled to see the new neurosurgeon until he completed twelve physical therapy sessions. (/d.) Only two physical therapy sessions had been scheduled for Plaintiff at that point, so Plaintiff again wrote to Defendant Martin, after which time, a third physical therapy session was scheduled and Plaintiff's Pamelor prescription was cancelled, with no substitute. (Id. at 15-16.)

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Wilson v. Seiter
501 U.S. 294 (Supreme Court, 1991)
Erickson v. Pardus
551 U.S. 89 (Supreme Court, 2007)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
In Re: Rockefeller Center Properties, Inc. Securities Litigation, Charal Investment Company Inc., a New Jersey Corporation C.W. Sommer & Co., a Texas Partnership, on Behalf of Themselves and All Others Similarly Situated Alan Freed Jerry Crance Helen Scozzanich Sheldon P. Langendorf Rita Walfield Robert Flashman Renee B. Fisher Foundation Inc. Frank Debora Wilson White Stanley Lloyd Kaufman, Jr. Joseph Gross v. David Rockefeller Goldman Sachs Mortgage Co. Goldman Sachs Group Lp Goldman Sachs & Co. Whitehall Street Real Estate Limited Partnership v. Wh Advisors Inc. v. Wh Advisors Lp v. Daniel M. Neidich Peter D. Linneman Richard M. Scarlata Frank Debora Wilson White Stanley Lloyd Kaufman, Jr. Joseph Gross, Charal Investment Company Inc., a New Jersey Corporation C.W. Sommer & Co., a Texas Partnership, on Behalf of Themselves and All Others Similarly Situated Alan Freed Jerry Crance Helen Scozzanich Sheldon P. Langendorf Rita Walfield Robert Flashman Renee B. Fisher Foundation Inc. Frank Debora Wilson White Stanley Lloyd Kaufman, Jr. Joseph Gross v. David Rockefeller Goldman Sachs Mortgage Co. Goldman Sachs Group Lp Goldman Sachs & Co. Whitehall Street Real Estate Limited Partnership v. Wh Advisors Inc. v. Wh Advisors Lp v. Daniel M. Neidich Peter D. Linneman Richard M. Scarlata Charal Investment Company Inc. C.W. Sommer & Co. Renee B. Fisher Foundation Helen Scozzanich Jerry Crance Alan Freed Sheldon P. Langendorf Rita Walfield Robert Flashman
311 F.3d 198 (Third Circuit, 2002)
Farmer v. Brennan
511 U.S. 825 (Supreme Court, 1994)
Collette Davis v. Abington Mem Hosp
765 F.3d 236 (Third Circuit, 2014)
Anthony Tenon v. William Dreibelbis
606 F. App'x 681 (Third Circuit, 2015)

Cite This Page — Counsel Stack

Bluebook (online)
Price v. Centurion of Delaware, LLC, Counsel Stack Legal Research, https://law.counselstack.com/opinion/price-v-centurion-of-delaware-llc-ded-2025.